- Home
- KMI vs SNN Comparison
KMI vs SNN Comparison
Compare KMI & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMI
- SNN
- Stock Information
- Founded
- KMI 1936
- SNN 1856
- Country
- KMI United States
- SNN United Kingdom
- Employees
- KMI N/A
- SNN N/A
- Industry
- KMI Natural Gas Distribution
- SNN Industrial Specialties
- Sector
- KMI Utilities
- SNN Health Care
- Exchange
- KMI Nasdaq
- SNN Nasdaq
- Market Cap
- KMI 59.2B
- SNN 13.2B
- IPO Year
- KMI 2011
- SNN 1999
- Fundamental
- Price
- KMI $27.68
- SNN $37.05
- Analyst Decision
- KMI Buy
- SNN Hold
- Analyst Count
- KMI 14
- SNN 3
- Target Price
- KMI $29.86
- SNN $31.50
- AVG Volume (30 Days)
- KMI 11.5M
- SNN 641.0K
- Earning Date
- KMI 10-15-2025
- SNN 10-30-2025
- Dividend Yield
- KMI 4.23%
- SNN 1.98%
- EPS Growth
- KMI 11.35
- SNN 59.91
- EPS
- KMI 1.22
- SNN 0.56
- Revenue
- KMI $15,969,000,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- KMI $11.25
- SNN $7.75
- Revenue Next Year
- KMI $5.46
- SNN $5.37
- P/E Ratio
- KMI $22.71
- SNN $66.38
- Revenue Growth
- KMI 3.97
- SNN 5.35
- 52 Week Low
- KMI $21.46
- SNN $23.69
- 52 Week High
- KMI $31.48
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- KMI 60.39
- SNN 52.68
- Support Level
- KMI $27.07
- SNN $37.10
- Resistance Level
- KMI $27.81
- SNN $37.64
- Average True Range (ATR)
- KMI 0.45
- SNN 0.40
- MACD
- KMI 0.12
- SNN -0.30
- Stochastic Oscillator
- KMI 87.66
- SNN 23.01
About KMI Kinder Morgan Inc.
Kinder Morgan is one of the largest midstream energy firms in the US, with an interest in or an operator on more than 80,000 miles of gas, refined products, and carbon dioxide pipelines. The company also owns one of the largest portfolios of gas and refined products storage and terminals. Most of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.